Rigaku Corp, Supplier for £1M Enhancement to X-ray Facility
News Apr 11, 2014
Rigaku Corporation is pleased to announce that it will be supplying X-ray equipment for a new state-of-the-art laboratory opening at the University of St Andrews today.
In attendance at the ribbon-cutting ceremony will be Dr Joseph Ferrara, Vice President, X-ray Research Laboratory, Rigaku Corporation. The Laboratory for Chemical Crystallography will be officially opened and directed by Alex Slawin, Professor of Chemical Crystallography at the university.
The newly updated facility, combining expertise with Rigaku, the leading Japanese manufacturer of X-ray related technologies, will support a wide range of cutting-edge research, including new green chemistry, drug discovery and materials applications, as well as the teaching of crystallography.
It will also be home to some of the most sophisticated X-ray technology in the world, supplied by Rigaku Corporation. The £1M enhancement (funded by EPSRC) includes new advanced detector and X-ray technology, featuring the most advanced X-ray generators, optics and Dectris detectors for the home lab. Rigaku is pleased to continue to be a partner in the development of the facility and looks forward to a long term relationship with St. Andrews.
Homemade Microscope Reveals How Viruses Cling to Our DNANews
Using a homemade, high-tech microscope, scientists at the School of Medicine have revealed how a cancer-causing virus anchors itself to our DNA. That discovery could pave the way for doctors to cure incurable diseases by flushing out viruses, including HPV and Epstein-Barr, that now permanently embed themselves in our cells.READ MORE
Neuropeptide Y Y1 Receptor Structure Solved, Offers New Opportunities for Anti-obesity Drug DiscoveryNews
Scientists solve the crystal structure of Neuropeptide Y Y1 Receptor, offering new opportunities for anti-obesity drug discovery.READ MORE
Crystal Structure of Neuropeptide 1 Receptor Solved, Providing Therapeutic Angle For Obesity TreatmentNews
An international team has uncovered the potential to beat obesity at the cellular level, characterizing for the first time a complex, little-understood receptor type that, when activated, shuts off hunger.READ MORE